Frequency of interferon-γ-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease

被引:159
作者
Laucella, SA
Postan, M
Martin, D
Fralish, BH
Albareda, MC
Alvarez, MG
Lococo, B
Barbieri, G
Viotti, RJ
Tarleton, RL [1 ]
机构
[1] Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA
[2] Univ Catolica Santiago del Estero, Ctr Chagas, Santiago Del Estero, Argentina
[3] Univ Catolica Santiago del Estero, Inst Biomed, Santiago Del Estero, Argentina
[4] Hosp Interzonal Gen Agudos Eva Peron, San Martin, Argentina
[5] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina
关键词
D O I
10.1086/381682
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study sought to quantify CD8(+) T cell responses to Trypanosoma cruzi and to identify potential links between these responses and the severity of disease in humans. In the majority of patients with Chagas disease, staining with class I major histocompatibility complex tetramers and analysis of interferon (IFN)-gamma ELISPOT responses to a panel of known cytotoxic T lymphocyte target epitopes from T. cruzi failed to identify parasite-specific CD8+ T cells. However, the frequency of individuals with positive ELISPOT responses was higher in areas of active transmission. Analysis of IFN-gamma ELISPOT responses to a parasite lysate revealed a very high frequency of responders among patients with mild clinical disease and a very low frequency of responders among those with the most severe form of the disease. These data suggest that the frequency of IFN-gamma producing T cells in patients with chronic Chagas disease is associated with the history of recent exposure and with the clinical status of the patient.
引用
收藏
页码:909 / 918
页数:10
相关论文
共 57 条
[1]  
Altfeld M, 2002, J CLIN INVEST, V109, P837, DOI 10.1172/JCI0214789
[2]   Myocardial parasite persistence in chronic Chagasic patients [J].
Añez, N ;
Carrasco, H ;
Parada, H ;
Crisante, G ;
Rojas, A ;
Fuenmayor, C ;
Gonzalez, N ;
Percoco, G ;
Borges, R ;
Guevara, P ;
Ramirez, JL .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (05) :726-732
[3]  
BEDNAREK MA, 1991, J IMMUNOL, V147, P4047
[4]  
Bonelo A, 2000, EUR J IMMUNOL, V30, P3079, DOI 10.1002/1521-4141(200011)30:11&lt
[5]  
3079::AID-IMMU3079&gt
[6]  
3.0.CO
[7]  
2-7
[8]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[9]  
ENGMAN DM, 1989, J BIOL CHEM, V264, P18627
[10]   NUCLEOTIDE-SEQUENCE AND TRANSCRIPTION OF A TRYPOMASTIGOTE SURFACE-ANTIGEN GENE OF TRYPANOSOMA-CRUZI [J].
FOUTS, DL ;
RUEF, BJ ;
RIDLEY, PT ;
WRIGHTSMAN, RA ;
PETERSON, DS ;
MANNING, JE .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1991, 46 (02) :189-200